Timing and Causes of Unplanned Readmissions After Percutaneous Coronary Intervention: Insights From the Nationwide Readmission Database.
cost
percutaneous coronary intervention
readmissions
Journal
JACC. Cardiovascular interventions
ISSN: 1876-7605
Titre abrégé: JACC Cardiovasc Interv
Pays: United States
ID NLM: 101467004
Informations de publication
Date de publication:
22 04 2019
22 04 2019
Historique:
received:
15
08
2018
revised:
23
01
2019
accepted:
05
02
2019
pubmed:
1
4
2019
medline:
9
6
2020
entrez:
1
4
2019
Statut:
ppublish
Résumé
The aim of this study was to describe the rates and causes of unplanned readmissions at different time periods following percutaneous coronary intervention (PCI). The rates and causes of readmission at different time periods after PCI remain incompletely elucidated. Patients undergoing PCI between 2010 and 2014 in the U.S. Nationwide Readmission Database were evaluated for the rates, causes, predictors, and costs of unplanned readmission between 0 and 7 days, 8 and 30 days, 31 and 90 days, and 91 and 180 days after index discharge. This analysis included 2,412,000 patients; 2.5% were readmitted between 0 and 7 days, 7.6% between 8 and 30 days, 8.9% between 31 and 90 days, and 8.0% between 91 and 180 days (cumulative rates 2.5%, 9.9%, 18.0%, and 24.8%, respectively). The majority of readmissions during each time period were due to noncardiac causes (53.1% to 59.6%). Nonspecific chest pain was the most common identifiable noncardiac cause for readmission during each time period (14.2% to 22.7% of noncardiac readmissions). Coronary artery disease including angina was the most common cardiac cause for readmission during each time period (37.4% to 39.3% of cardiac readmissions). The second most common cardiac cause for readmission was acute myocardial infarction between 0 and 7 days (27.6% of cardiac readmissions) and heart failure during all subsequent time periods (22.2% to 23.7% of cardiac readmissions). Approximately 25% of patients following PCI have unplanned readmissions within 6 months. Causes of readmission depend on the timing at which they are assessed, with noncardiovascular causes becoming more important at longer time points.
Sections du résumé
OBJECTIVES
The aim of this study was to describe the rates and causes of unplanned readmissions at different time periods following percutaneous coronary intervention (PCI).
BACKGROUND
The rates and causes of readmission at different time periods after PCI remain incompletely elucidated.
METHODS
Patients undergoing PCI between 2010 and 2014 in the U.S. Nationwide Readmission Database were evaluated for the rates, causes, predictors, and costs of unplanned readmission between 0 and 7 days, 8 and 30 days, 31 and 90 days, and 91 and 180 days after index discharge.
RESULTS
This analysis included 2,412,000 patients; 2.5% were readmitted between 0 and 7 days, 7.6% between 8 and 30 days, 8.9% between 31 and 90 days, and 8.0% between 91 and 180 days (cumulative rates 2.5%, 9.9%, 18.0%, and 24.8%, respectively). The majority of readmissions during each time period were due to noncardiac causes (53.1% to 59.6%). Nonspecific chest pain was the most common identifiable noncardiac cause for readmission during each time period (14.2% to 22.7% of noncardiac readmissions). Coronary artery disease including angina was the most common cardiac cause for readmission during each time period (37.4% to 39.3% of cardiac readmissions). The second most common cardiac cause for readmission was acute myocardial infarction between 0 and 7 days (27.6% of cardiac readmissions) and heart failure during all subsequent time periods (22.2% to 23.7% of cardiac readmissions).
CONCLUSIONS
Approximately 25% of patients following PCI have unplanned readmissions within 6 months. Causes of readmission depend on the timing at which they are assessed, with noncardiovascular causes becoming more important at longer time points.
Identifiants
pubmed: 30928446
pii: S1936-8798(19)30491-1
doi: 10.1016/j.jcin.2019.02.007
pmc: PMC6843988
mid: NIHMS1056822
pii:
doi:
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
734-748Subventions
Organisme : CSRD VA
ID : IK2 CX001074
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Références
Circ Cardiovasc Interv. 2015 Apr;8(4):null
pubmed: 25825007
Qual Manag Health Care. 2014 Jul-Sep;23(3):169-77
pubmed: 24978166
J Invasive Cardiol. 2013 Aug;25(8):397-401
pubmed: 23913604
EuroIntervention. 2018 Oct 20;14(8):926-934
pubmed: 29360067
Med Care. 2006 Nov;44(11):972-81
pubmed: 17063128
J Am Heart Assoc. 2018 Sep 18;7(18):e009863
pubmed: 30371187
JAMA Intern Med. 2014 Feb 1;174(2):186-93
pubmed: 24247275
Health Care Financ Rev. 2008 Fall;30(1):75-91
pubmed: 19040175
J Am Coll Cardiol. 2015 Sep 1;66(9):1036-45
pubmed: 26314532
JACC Cardiovasc Interv. 2014 Jan;7(1):1-9
pubmed: 24456715
Circ Cardiovasc Qual Outcomes. 2012 Mar 1;5(2):229-35
pubmed: 22373903
Ann Intern Med. 2012 Jul 3;157(1):1-10
pubmed: 22751755
Am J Cardiol. 2018 Jul 15;122(2):220-228
pubmed: 29861049
Int J Cardiol. 2017 Jan 15;227:370-377
pubmed: 27839805
PLoS One. 2014 Feb 14;9(2):e88577
pubmed: 24551120
Pol Merkur Lekarski. 2006 Jan;20(115):104-8
pubmed: 16617748
Circ Cardiovasc Qual Outcomes. 2016 Sep;9(5):600-4
pubmed: 27553598
Eur Heart J. 2015 Jul 1;36(25):1618-28
pubmed: 25896077
JACC Cardiovasc Interv. 2012 Sep;5(9):958-65
pubmed: 22995883
JACC Cardiovasc Interv. 2018 Apr 9;11(7):665-674
pubmed: 29622145
Hosp Pract (1995). 2015;43(2):70-3
pubmed: 25761913
Hellenic J Cardiol. 2009 Sep-Oct;50(5):379-87
pubmed: 19767279
Am J Cardiol. 2018 Apr 1;121(7):810-817
pubmed: 29448978
JAMA. 2011 Oct 19;306(15):1688-98
pubmed: 22009101
Open Heart. 2014 Feb 13;1(1):e000021
pubmed: 25332786
Cardiology. 2013;126(1):35-40
pubmed: 23860246
J Manag Care Pharm. 2013 Sep;19(7):558-63
pubmed: 23964617